Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

A Topical Solution for Chronic Pain

Pain impedes the life of millions around the world, and the market for topical creams to treat this pain is growing at an accelerated rate as people choose to treat pain directly vs ingesting pain killers. Some analysts, such as those at Allied Market Research, project that ...

Biopharma's Phase 3 Trial Results in Migraine 'Robust,' 'Impressive'

These topline data and next steps for the therapeutic are reviewed in a Ladenburg Thalmann report. In a Dec. 30 research note, analyst Matthew Kaplan reported that Ladenburg Thalmann increased its price target on Buy-rated Axsome Therapeutics Inc. (AXSM:NASDAQ) to $...

The New Cannabis & CBD Therapy for PTSD

This podcast is part of our StockTalk Cannabis Sector CEO interview series, and our mission going forward is to help listeners and investors understand more about investment opportunities in the public cannabis marketplace. There are around eight million people in the U...

Small-Cap Stocks (Russell 2k) Are Headed For A Double Dip?

Our research team believes the Russell 2000 is leading the way in terms of technical analysis and future expectations. While the NASDAQ has rallied as a result of US Fed stimulus and foreign investor activity, the Russell 2000 has set up a very clear price resistance level n...

What ECB’s Tiering Means for Gold

In a key policy shift, the ECB has recently introduced tiered system of interest rates. This news isn’t of interest only to the banks keeping their reserves at the ECB. In today’s article, you’ll learn about the new instrument of...

Could DehydraTECH CBD be Worth $3 Billion a Year to Lexaria?

PCG Digital -- Hypertension, or high blood pressure as it's commonly known, affects over three million Americans every year and is a primary or contributing cause of death for 25% of them. On a global scale, hypertension kills roughly 7.6 milli on people per year . L...

Neovasc Shares Climb 80% Upon FDA Premarket Approval Filing for Refractory Angina Device

Shares of specialty cardiovascular medical device company Neovasc Inc. opened more than 100% higher after the firm reported that it submitted a Premarket Approval application to the FDA for its Neovasc Reducer device for use in the treatment of refractory angina. This...

Technical Analyst: Silver Looks Bearish Short to Medium Term

Technical analyst Clive Maund charts silver and explains why he is bearish in the short to medium term. Whichever way you cut it, silver's chart looks bearish for the short to medium term, but against this we must set its rapidly improving COT structure and ...

Will the US Solar energy industry survive the COVID-19 crisis?

There are hardly any sectors not affected by Covid-19, including the US solar industry. The US solar industry is affected by compounding issues, delays in supply chains, strengthening the tax equity market, financial concerns of homeowners, shelter-in-place orders, and challen...

Gold Daily News: Tuesday, March 3

The gold futures contract gained 1.79% on Monday, as it retraced some of the Friday’s big sell-off. On Friday the price collapsed to $1,564.00 level, despite the ongoing corona virus scare. The recent short-term volatility marked a topping pattern before ...
1 2 3 4 5 6 7 8 9 10 ...